Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Aging|September 19, 2019
Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancerPatrick Lebok, Aurelia von Hassel, Jan Meiners, et al.
The American Journal of Surgical Pathology|August 12, 2024
Prevalence of S-methyl-5'-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors From 149 Different Tumor TypesNatalia Gorbokon, Niklas Wößner, Maximilian Lennartz, et al.
Plos One|April 2, 2025
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumorsSeyma Büyücek, Florian Viehweger, Viktor Reiswich, et al.
Virchows Archiv : an International Journal of Pathology|June 15, 2025
High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumorsViktoria Chirico, Fatih Baybars Ergüven, Katharina Möller, et al.
Diagnostics (Basel, Switzerland)|August 14, 2025
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor PhenotypeViktoria Chirico, Hena Sharifi, Maria Christina Tsourlakis, et al.
Plos One|January 24, 2025
Correction: High prevalence of p16 staining in malignant tumorsNoémi De Wispelaere, Sebastian Dwertmann Rico, Marcus Bauer, et al.
Biomarker Research|December 10, 2024
Prevalence and clinical significance of Claudin-3 expression in cancer: a tissue microarray study on 14,966 tumor samplesSeyma Büyücek, Nina Schraps, Anne Menz, et al.
Diagnostic Pathology|January 13, 2024
Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entitiesFlorian Viehweger, Carola Böcker, Sören Weidemann, et al.
Cancers|July 13, 2024
Stimulator of Interferon Genes Protein (STING) Expression in Cancer Cells: A Tissue Microarray Study Evaluating More than 18,000 Tumors from 139 Different Tumor EntitiesAnne Menz, Julia Zerneke, Florian Viehweger, et al.
The American Journal of Surgical Pathology|January 25, 2024
GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the PancreasMaximilian Lennartz, Nick Benjamin Dünnebier, Doris Höflmayer, et al.
Pageof 10